Literature DB >> 2222386

Types and correlates of blood/injury-related vasovagal syncope.

R A Kleinknecht1, J Lenz, G Ford, S DeBerard.   

Abstract

This study investigated by interview, the initial syncopal episode of 103 blood/injury-related vasovagal fainters in order to examine two competing hypotheses concerning their origins. Graham (Circulation, 23, 901-906, 1961) postulated that the faint resulted when sympathetic nervous system (SNS) activity ceased on termination of a threat, leaving parasympathetic nervous system (PNS) activation unopposed. Engel [Fainting (2nd edn), 1962; Annals of Internal Medicine, 89, 901-906, 1978] proposed that when in the face of threat with SNS activation, escape is blocked, the PNS becomes activated as the conservation-withdrawal response, leading to syncope. We found cases clearly conforming to each of these formulations as well as some with characteristics of both, and some who fainted in response to blood or injury but with no perception of threat. The Graham and Engel types did not differ in terms of fear or avoidance of blood, injury, or medically-related situations nor did they differ in the frequency with which their parents reported blood/injury-related syncopal episodes. It is proposed that both may be activated by a common psychological mechanism involving cessation of a defensive posture. In contrast, the non-threat fainters showed significantly less medically-related avoidance and had a greater percentage (94%) of parents with positive faint histories.

Entities:  

Mesh:

Year:  1990        PMID: 2222386     DOI: 10.1016/0005-7967(90)90080-3

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  2 in total

1.  A novel psychophysiological treatment for vasovagal syncope.

Authors:  R K Khurana; J J Lynch; F W Craig
Journal:  Clin Auton Res       Date:  1997-08       Impact factor: 4.435

Review 2.  The Search for the Genes of Vasovagal Syncope.

Authors:  Robert S Sheldon; Roopinder K Sandhu
Journal:  Front Cardiovasc Med       Date:  2019-11-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.